Fully understanding patient behavior, physician preference and healthcare system choice is just as critical as clinical data in determining disease states, trajectories and treatment sequences. And with real world evidence, patient reported outcomes and digital health data becoming more prevalent, life sciences companies are now compelled to harness the power of real-time actionable insights in order to respond to constantly shifting patient, provider and payer needs, wants and demand.  

Enter Signals Analytics, creators of the only cloud-based analytical intelligence platform that transforms the world's unconnected data into actionable insights to enhance therapeutic outcomes, optimize product portfolio health and propel patient-centered innovation.  With our revolutionary Decision Science as a Service platform, future therapeutic achievement is no longer purely within the realm of science and technology, but extends to "beyond the pill" services and integrated care models that drive adherence.


Analytical Intelligence Solutions


Elevate Peak Sales

by uncovering value levers, increasing treatment adherence, broadening provider adoption and minimizing switching to alternatives

Optimize Pipeline

by moving beyond the pill to refine new modalities of treatment, digital health offerings and omnichannel patient engagement strategies

Accelerate Your
Innovation Agenda

by intercepting disease progressions, identifying patient population trends and evaluating buy, build or partner scenarios

Just a Few of Our Clients

Signals Creates Value for the Pharmaceutical Industry


Improving Patient Engagement, Adherence and Outcomes

Optimizing Patient-Centric Innovation and “Beyond the Pill” Initiatives

Driving Business Actions that Maximize Opportunities


Driving Organizational
Effectiveness and Efficiency

Lowering the Risk of
Commercial Decisionmaking


We Deliver Actionable Insights Across the Therapeutic Lifecycle


Real Time Intelligence During the Patient Treatment Journey

Our Proven Results

A Top 30 Global Life Sciences Company Overcomes Marginalization by Generic Equivalents


Actionable Insights that Drive Superior Business Outcomes

  • Market & Competitive Intelligence
  • Disease Interception, States, Patterns & Progressions Analysis

  • Analyze Patient and Provider Selection Intent & Propensity to Comply

  • Omnichannel Patient and Provider Experience 

  • Emerging Patient Population Trending

  • Treatment Adherence, Substitutes & Alternatives

  • Digital Pharmocoviligence Surveillance

  • Commercialization Effectiveness & Efficiency
  • Patient and Provider Sentiment & Loyalty

  • Key Opinion Leader Impact

  • Unmet, Under-Addressed and Hidden Patient and Provider Needs

  • NME Whitespace and Opportunity Horizons

  • Jobs to be Done, Size of the Prize and Market Inertia

  • Buy, Build or Partner Scenarios


The Signals Difference


Precision Intelligence That Matters Most to Your Enterprise

Real Time Signals Detection with Validated Source Data  

Built By Industry Experts For Industry Experts

Rapid Business Impact and Value Right Out of the Box

Machine Learning Combined with Human Intelligence


The Latest From Signals

Let's Talk


Signals Headquarters
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
(917) 470 9110

Signals Labs
7 Giborei Israel St.
P.O.B 8374, Netanya 4250407, Israel
+972 73 718 1650

Signals Europe
Av. de Sécheron 15,
1202 Geneva, Switzerland
+41 22 575 5045

All Offices

Sales: Sales@signals-analytics.com

Support: Support@signals-analytics.com

Careers: Careers@signals-analytics.com

General Information: Info@signals-analytics.com

Inquiries or Request a Demo